Hester Biosciences' stock rises over 5% on Q3 result

Hester Biosciences, a leading animal health care company, posted  a net profit of Rs 65.01 million against Rs 58.21 million for the previous year, registering a growth of 12%.
 
The company's stock was trading 5.57% up at Rs 1713 at 1.34 pm after trailing over 4% in the last two weeks. 
 
Hester has reported a net sales of Rs 319.25 million in Q3FY18 compared to Rs 290.94 million for the previous corresponding period, thereby, registering a growth of 10%. 
 
Earnings per share for the Q3FY18 is at Rs 7.64 against Rs 6.84 for Q3FY17.
 
Hester has reported a net sales of Rs 977.69 million in the nine months ended FY18 as compared to Rs 899.83 million for the previous corresponding period, registering a growth of 9%.
 
Net Profit for the nine months ended FY18 is recorded at Rs 215.44 million against Rs 178.29 million for the previous corresponding period, registering a growth of 21%.
 
Earnings per share for nine months ended FY18 is at Rs 25.33 as against Rs 20.96 for the nine months ended FY17.